Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo.

Oliveira C, Granja S, Neves NM, Reis RL, Baltazar F, Silva TH, Martins A.

Carbohydr Polym. 2019 Nov 1;223:115034. doi: 10.1016/j.carbpol.2019.115034. Epub 2019 Jun 28.

PMID:
31426965
2.

Immunity, Hypoxia and Metabolism - the ménage à trois of cancer: implications for immunotherapy.

Riera-Domingo C, Audigé A, Granja S, Cheng WC, Ho PC, Baltazar F, Stockmann C, Mazzone M.

Physiol Rev. 2019 Aug 15. doi: 10.1152/physrev.00018.2019. [Epub ahead of print]

PMID:
31414610
3.

Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display.

Ferreira D, Silva AP, Nobrega FL, Martins IM, Barbosa-Matos C, Granja S, Martins SF, Baltazar F, Rodrigues LR.

Sci Rep. 2019 Mar 8;9(1):3958. doi: 10.1038/s41598-019-40562-1.

4.

Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.

Afonso J, Pinto T, Simões-Sousa S, Schmitt F, Longatto-Filho A, Pinheiro C, Marques H, Baltazar F.

Cell Oncol (Dordr). 2019 Jun;42(3):303-318. doi: 10.1007/s13402-019-00426-2. Epub 2019 Feb 21.

PMID:
30790227
5.

Role of adiponectin as a modulator of testicular function during aging in mice.

Choubey M, Ranjan A, Bora PS, Baltazar F, Martin LJ, Krishna A.

Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):413-427. doi: 10.1016/j.bbadis.2018.11.019. Epub 2018 Nov 22.

PMID:
30471430
6.

Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment.

Pontes O, Costa M, Santos F, Sampaio-Marques B, Dias T, Ludovico P, Baltazar F, Proença F.

Eur J Med Chem. 2018 Sep 5;157:101-114. doi: 10.1016/j.ejmech.2018.07.058. Epub 2018 Jul 26.

PMID:
30081238
7.

Direct actions of adiponectin on changes in reproductive, metabolic, and anti-oxidative enzymes status in the testis of adult mice.

Choubey M, Ranjan A, Bora PS, Baltazar F, Krishna A.

Gen Comp Endocrinol. 2019 Aug 1;279:1-11. doi: 10.1016/j.ygcen.2018.06.002. Epub 2018 Jun 15.

PMID:
29908833
8.

The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications.

Gomes SD, Oliveira CS, Azevedo-Silva J, Casanova M, Barreto J, Pereira H, Chaves S, Rodrigues L, Casal M, Corte-Real M, Baltazar F, Preto A.

Curr Med Chem. 2018 May 29. doi: 10.2174/0929867325666180530102050. [Epub ahead of print]

PMID:
29848266
9.

Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy.

Tavares-Valente D, Granja S, Baltazar F, Queirós O.

J Cell Mol Med. 2018 May 29. doi: 10.1111/jcmm.13642. [Epub ahead of print]

10.

The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors.

Silva ECA, Cárcano FM, Bonatelli M, Zaia MG, Morais-Santos F, Baltazar F, Lopes LF, Scapulatempo-Neto C, Pinheiro C.

Oncotarget. 2018 Apr 17;9(29):20386-20398. doi: 10.18632/oncotarget.24910. eCollection 2018 Apr 17.

11.

Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells.

Miranda-Gonçalves V, Cardoso-Carneiro D, Valbom I, Cury FP, Silva VA, Granja S, Reis RM, Baltazar F, Martinho O.

Oncotarget. 2017 Oct 10;8(61):103657-103670. doi: 10.18632/oncotarget.21761. eCollection 2017 Nov 28.

12.

Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.

Vieira de Castro J, Gomes ED, Granja S, Anjo SI, Baltazar F, Manadas B, Salgado AJ, Costa BM.

J Transl Med. 2017 Oct 2;15(1):200. doi: 10.1186/s12967-017-1303-8.

13.

GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior.

Pinheiro C, Granja S, Longatto-Filho A, Faria AM, Fragoso MCBV, Lovisolo SM, Bonatelli M, Costa RFA, Lerário AM, Almeida MQ, Baltazar F, Zerbini MCN.

Oncotarget. 2017 Jul 10;8(38):63835-63845. doi: 10.18632/oncotarget.19135. eCollection 2017 Sep 8.

14.

Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications.

Ferro S, Azevedo-Silva J, Casal M, Côrte-Real M, Baltazar F, Preto A.

Oncotarget. 2016 Sep 21;7(43):70639-70653. doi: 10.18632/oncotarget.12156. eCollection 2016 Oct 25.

15.

Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk.

Miranda-Gonçalves V, Bezerra F, Costa-Almeida R, Freitas-Cunha M, Soares R, Martinho O, Reis RM, Pinheiro C, Baltazar F.

Mol Carcinog. 2017 Dec;56(12):2630-2642. doi: 10.1002/mc.22707. Epub 2017 Aug 25.

PMID:
28762551
16.

Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy.

Ferreira NN, M B Ferreira L, Miranda-Gonçalves V, Reis RM, Seraphim TV, Borges JC, Baltazar F, Gremião MPD.

Eur J Pharm Biopharm. 2017 Oct;119:271-282. doi: 10.1016/j.ejpb.2017.06.028. Epub 2017 Jun 29.

PMID:
28669796
17.

HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors.

Martinho O, Silva-Oliveira R, Cury FP, Barbosa AM, Granja S, Evangelista AF, Marques F, Miranda-Gonçalves V, Cardoso-Carneiro D, de Paula FE, Zanon M, Scapulatempo-Neto C, Moreira MA, Baltazar F, Longatto-Filho A, Reis RM.

Theranostics. 2017 Jan 15;7(3):717-732. doi: 10.7150/thno.17154. eCollection 2017.

18.

Value of pH regulators in the diagnosis, prognosis and treatment of cancer.

Granja S, Tavares-Valente D, Queirós O, Baltazar F.

Semin Cancer Biol. 2017 Apr;43:17-34. doi: 10.1016/j.semcancer.2016.12.003. Epub 2017 Jan 5. Review.

PMID:
28065864
19.

The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation.

Rossi ED, Bizzarro T, Granja S, Martini M, Capodimonti S, Luca E, Fadda G, Lombardi CP, Pontecorvi A, Larocca LM, Baltazar F, Schmitt F.

Endocrine. 2017 May;56(2):379-387. doi: 10.1007/s12020-016-1044-0. Epub 2016 Aug 2.

PMID:
27484771
20.

Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.

Martins SF, Amorim R, Viana-Pereira M, Pinheiro C, Costa RF, Silva P, Couto C, Alves S, Fernandes S, Vilaça S, Falcão J, Marques H, Pardal F, Rodrigues M, Preto A, Reis RM, Longatto-Filho A, Baltazar F.

BMC Cancer. 2016 Jul 26;16:535. doi: 10.1186/s12885-016-2566-9.

21.

The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.

Azevedo-Silva J, Queirós O, Baltazar F, Ułaszewski S, Goffeau A, Ko YH, Pedersen PL, Preto A, Casal M.

J Bioenerg Biomembr. 2016 Aug;48(4):349-62. doi: 10.1007/s10863-016-9670-z. Epub 2016 Jul 25. Review.

PMID:
27457582
22.

Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.

Miranda-Gonçalves V, Granja S, Martinho O, Honavar M, Pojo M, Costa BM, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa P, Reis RM, Baltazar F.

Oncotarget. 2016 Jul 19;7(29):46335-46353. doi: 10.18632/oncotarget.10114.

23.

Prognostic significance of monocarboxylate transporter expression in oral cavity tumors.

Simões-Sousa S, Granja S, Pinheiro C, Fernandes D, Longatto-Filho A, Laus AC, Alves CD, Suárez-Peñaranda JM, Pérez-Sayáns M, Lopes Carvalho A, Schmitt FC, García-García A, Baltazar F.

Cell Cycle. 2016 Jul 17;15(14):1865-73. doi: 10.1080/15384101.2016.1188239. Epub 2016 May 27.

24.

Absence of microsatellite instability and BRAF (V600E) mutation in testicular germ cell tumors.

Cárcano FM, Lengert AH, Vidal DO, Scapulatempo Neto C, Queiroz L, Marques H, Baltazar F, Berardinelli GN, Martinelli CM, da Silva EC, Reis RM, Lopes LF.

Andrology. 2016 Sep;4(5):866-72. doi: 10.1111/andr.12200. Epub 2016 May 6.

25.

The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.

Pinheiro C, Miranda-Gonçalves V, Longatto-Filho A, Vicente AL, Berardinelli GN, Scapulatempo-Neto C, Costa RF, Viana CR, Reis RM, Baltazar F, Vazquez VL.

Cell Cycle. 2016 Jun 2;15(11):1462-70. doi: 10.1080/15384101.2016.1175258. Epub 2016 Apr 22.

26.

Transcription-coupled repair of UV damage in the halophilic archaea.

Stantial N, Dumpe J, Pietrosimone K, Baltazar F, Crowley DJ.

DNA Repair (Amst). 2016 May;41:63-68. doi: 10.1016/j.dnarep.2016.03.007. Epub 2016 Apr 6.

PMID:
27088618
27.

Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas.

Miranda-Gonçalves V, Reis RM, Baltazar F.

Curr Cancer Drug Targets. 2016;16(5):388-99. Review.

PMID:
26694251
28.

Colon Cancer Chemoprevention by Sage Tea Drinking: Decreased DNA Damage and Cell Proliferation.

Pedro DF, Ramos AA, Lima CF, Baltazar F, Pereira-Wilson C.

Phytother Res. 2016 Feb;30(2):298-305. doi: 10.1002/ptr.5531. Epub 2015 Dec 14.

PMID:
26661587
29.

Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness.

Afonso J, Santos LL, Morais A, Amaro T, Longatto-Filho A, Baltazar F.

Cell Cycle. 2016;15(3):368-80. doi: 10.1080/15384101.2015.1121329. Epub 2015 Dec 4.

30.

Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.

Pinheiro C, Granja S, Longatto-Filho A, Faria AM, Fragoso MC, Lovisolo SM, Lerário AM, Almeida MQ, Baltazar F, Zerbini MC.

Oncotarget. 2015 Dec 29;6(42):44403-21. doi: 10.18632/oncotarget.5623.

31.

Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.

Cárcano FM, Vidal DO, van Helvoort Lengert A, Neto CS, Queiroz L, Marques H, Baltazar F, da Silva Martinelli CM, Soares P, da Silva EC, Lopes LF, Reis RM.

Tumour Biol. 2016 Apr;37(4):4901-7. doi: 10.1007/s13277-015-4317-y. Epub 2015 Nov 3.

PMID:
26526580
32.

Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas.

Pinheiro C, Garcia EA, Morais-Santos F, Moreira MA, Almeida FM, Jubé LF, Queiroz GS, Paula ÉC, Andreoli MA, Villa LL, Longatto-Filho A, Baltazar F.

BMC Cancer. 2015 Nov 2;15:835. doi: 10.1186/s12885-015-1842-4.

33.

Glucose Addiction in Cancer Therapy: Advances and Drawbacks.

Granja S, Pinheiro C, Reis RM, Martinho O, Baltazar F.

Curr Drug Metab. 2015;16(3):221-42. Review.

PMID:
26504932
34.

Targeting lactate transport suppresses in vivo breast tumour growth.

Morais-Santos F, Granja S, Miranda-Gonçalves V, Moreira AH, Queirós S, Vilaça JL, Schmitt FC, Longatto-Filho A, Paredes J, Baltazar F, Pinheiro C.

Oncotarget. 2015 Aug 7;6(22):19177-89.

35.

Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development.

Silva-Carvalho R, Baltazar F, Almeida-Aguiar C.

Evid Based Complement Alternat Med. 2015;2015:206439. doi: 10.1155/2015/206439. Epub 2015 May 27. Review.

36.

Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria.

Oliveira CS, Pereira H, Alves S, Castro L, Baltazar F, Chaves SR, Preto A, Côrte-Real M.

Cell Death Dis. 2015 Jun 18;6:e1788. doi: 10.1038/cddis.2015.157.

37.

Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.

Amorim R, Pinheiro C, Miranda-Gonçalves V, Pereira H, Moyer MP, Preto A, Baltazar F.

Cancer Lett. 2015 Aug 28;365(1):68-78. doi: 10.1016/j.canlet.2015.05.015. Epub 2015 May 25.

PMID:
26021766
38.

SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.

Vieira FQ, Costa-Pinheiro P, Almeida-Rios D, Graça I, Monteiro-Reis S, Simões-Sousa S, Carneiro I, Sousa EJ, Godinho MI, Baltazar F, Henrique R, Jerónimo C.

Oncotarget. 2015 May 30;6(15):13644-57.

39.

Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.

Granja S, Marchiq I, Le Floch R, Moura CS, Baltazar F, Pouysségur J.

Oncotarget. 2015 Mar 30;6(9):6708-21.

40.

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.

Pertega-Gomes N, Felisbino S, Massie CE, Vizcaino JR, Coelho R, Sandi C, Simoes-Sousa S, Jurmeister S, Ramos-Montoya A, Asim M, Tran M, Oliveira E, Lobo da Cunha A, Maximo V, Baltazar F, Neal DE, Fryer LG.

J Pathol. 2015 Aug;236(4):517-30. doi: 10.1002/path.4547.

41.

Impact of an educational hands-on project on the antimicrobial, antitumor and anti-inflammatory properties of plants on Portuguese students' awareness, knowledge, and competences.

Azevedo MM, Pinheiro C, Dias AC, Pinto-Ribeiro F, Baltazar F.

Int J Environ Res Public Health. 2015 Feb 23;12(3):2437-53. doi: 10.3390/ijerph120302437.

42.

The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH.

Azevedo-Silva J, Queirós O, Ribeiro A, Baltazar F, Young KH, Pedersen PL, Preto A, Casal M.

Biochem J. 2015 Apr 15;467(2):247-58. doi: 10.1042/BJ20140921.

PMID:
25641640
43.

Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer.

Valença I, Pértega-Gomes N, Vizcaino JR, Henrique RM, Lopes C, Baltazar F, Ribeiro D.

J Cell Mol Med. 2015 Apr;19(4):723-33. doi: 10.1111/jcmm.12481. Epub 2015 Jan 30.

44.

Lactate transporters in the context of prostate cancer metabolism: what do we know?

Pértega-Gomes N, Baltazar F.

Int J Mol Sci. 2014 Oct 13;15(10):18333-48. doi: 10.3390/ijms151018333. Review.

45.

Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix.

Pinheiro C, Garcia EA, Morais-Santos F, Scapulatempo-Neto C, Mafra A, Steenbergen RD, Boccardo E, Villa LL, Baltazar F, Longatto-Filho A.

BMC Cancer. 2014 Oct 8;14:751. doi: 10.1186/1471-2407-14-751.

46.

The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.

Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, Baltazar F, Paredes J.

BMC Cancer. 2014 Oct 1;14:734. doi: 10.1186/1471-2407-14-734.

47.

CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.

Afonso J, Santos LL, Miranda-Gonçalves V, Morais A, Amaro T, Longatto-Filho A, Baltazar F.

Mol Carcinog. 2015 Nov;54(11):1451-66. doi: 10.1002/mc.22222. Epub 2014 Sep 27.

PMID:
25263481
48.

Characterization of monocarboxylate transporter activity in hepatocellular carcinoma.

Alves VA, Pinheiro C, Morais-Santos F, Felipe-Silva A, Longatto-Filho A, Baltazar F.

World J Gastroenterol. 2014 Sep 7;20(33):11780-7. doi: 10.3748/wjg.v20.i33.11780.

49.

T-box transcription factor brachyury is associated with prostate cancer progression and aggressiveness.

Pinto F, Pértega-Gomes N, Pereira MS, Vizcaíno JR, Monteiro P, Henrique RM, Baltazar F, Andrade RP, Reis RM.

Clin Cancer Res. 2014 Sep 15;20(18):4949-61. doi: 10.1158/1078-0432.CCR-14-0421. Epub 2014 Jul 9.

50.

Monocarboxylate transporters as targets and mediators in cancer therapy response.

Baltazar F, Pinheiro C, Morais-Santos F, Azevedo-Silva J, Queirós O, Preto A, Casal M.

Histol Histopathol. 2014 Dec;29(12):1511-24. doi: 10.14670/HH-29.1511. Epub 2014 Jun 12. Review.

PMID:
24921258

Supplemental Content

Loading ...
Support Center